Key highlights
While COVID-19 has created much of the noise in the healthcare sector for the last 2 years, there remain many other opportunities and challenges.
Our latest infographic explores some of the key themes for 2022 and beyond, including:
- What’s behind the considerable buzz in the biosimilars market?
- Which key biologics are set to lose patent protection by 2024?
- Is 2022 going to be another bumper year for M&A?
- How has AI and Pharma interplay evolved over time?
To download your copy please complete the form to the right ->
